1-4 of 4
Jean-Didier Rain, MD
Close
Sort by
Journal Articles

Complete Hematological, Molecular and Histological Remissions without Cytoreductive Treatment Lasting After Pegylated-Interferon α-2a (peg-IFNα-2a) Therapy in Polycythemia Vera (PV): Long Term Results of a Phase 2 Trial

Pascal Turlure, MD, Nathalie Cambier, MD, Murielle Roussel, Sylvia Bellucci, MD, PhD, Jean-Marc Zini, MD, PhD, Jean-Didier Rain, MD, Philippe Rousselot, MD, PhD, William Vainchenker, MD, PhD, Lina Abdelkader, Kamel Ghomari, Jean-Luc Dutel, Yasmine Chait, Sylvie Chevret, Christine Chomienne, MD, PhD, Bruno Cassinat, PharmD, Jean-Jacques Kiladjian, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 280.
https://doi.org/10.1182/blood.V118.21.280.280
Published: 2011
Journal Articles

Peg IFNα-2a in Polycythemia Vera (PV). Results of a Phase 2 Study by the French “PV-NORD” Group.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Nathalie Cambier, MD, Sylvia Bellucci, MD,PhD, Murielle Roussel, MD, Marie-José Grange, MD, Bernard Grandchamp, MD,PhD, Jean-Didier Rain, MD,PhD, Christine Chomienne, MD,PhD, Pierre Fenaux, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 670.
https://doi.org/10.1182/blood.V108.11.670.670
Published: 2006
Journal Articles

Response Assessment after an Inductive CHOP or CHOP-Like Regimen with or without Rituximab in 103 Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Integrating 18 Fluorodeoxyglucose Positron Emission Tomography (PET) to the International Workshop Criteria (IWC).

Jehan Dupuis, MD, Emmanuel Itti, MD,PhD, Alain Rahmouni, MD,PhD, Jean-Didier Rain, MD,PhD, Christian Gisselbrecht, MD,PhD, Karim Belhadj, MD, Taoufik El Gnaoui, MD, Isabelle Gaillard, MD, Chieh Lin, MD, Nicolas Mounier, MD,PhD, Philippe Gaulard, MD,PhD, Michel Meignan, MD,PhD, Felix Reyes, MD,PhD, Corinne Haioun, MD
Journal: Blood
Blood (2006) 108 (11): 2735.
https://doi.org/10.1182/blood.V108.11.2735.2735
Published: 2006
Journal Articles

PVN1: A Phase 2 Study of Pegylated Interferon-α2a in Polycythemia Vera (PV) by the “PV-Nord” Group. Preliminary Report of Efficacy and Safety.

Jean-Jacques Kiladjian, MD, Bruno Cassinat, MD, Pascal Turlure, MD, Sylvia Bellucci, MD, Nathalie Cambier, MD, Murielle Roussel, MD, Marie-José Grange, MD, Jean-Didier Rain, MD, Christine Chomienne, MD, Pierre Fenaux, MD
Journal: Blood
Blood (2005) 106 (11): 4940.
https://doi.org/10.1182/blood.V106.11.4940.4940
Published: 2005